Taliossa

Savonix, Inc. is a company that develops an evidence-based digital neuro-cognitive assessment platform aimed at enhancing brain health. Its flagship product, Savonix Mobile, allows users to conduct clinically recognized cognitive assessments directly on their mobile devices. This platform serves a diverse clientele, including healthcare providers, researchers, and large corporations, enabling them to evaluate cognitive function in various domains such as memory and cognitive flexibility. The assessments are guided and reported by a virtual clinician, facilitating the understanding of risks associated with dementia and other brain disorders. Notably, Savonix incorporates a unique 3D game platform that derives insights into cognitive functions, such as Implicit Learning, from user interactions within the app. Founded in 2014 and based in San Francisco, Savonix has established strategic partnerships with institutions like New York University and several biotechnology firms to enhance its offerings and impact in the field of cognitive health.